Core Viewpoint - The company emphasizes its platform-based development model, which allows for diversification across multiple products and markets, enhancing resilience against market uncertainties [1] Group 1: Company Strategy - The management team possesses extensive experience in platform-based company management, aligning with industry development characteristics and long-term strategic planning [1] - The company is expanding in four major business segments: in vitro diagnostics, clinical medicine, dermatology and aesthetics, and consumer health, leveraging 17 years of technological accumulation and channel resource development [1] Group 2: Competitive Advantage - The multi-product and multi-market approach creates a unique competitive advantage, supporting the company's potential for sustained and stable growth in the long term [1]